Nadroparin Calcium — Drug Intelligence | 6 EU Trials

Filter these 6 trials by condition, phase, country and more.

6 Registered trials

4 Recruiting

1 Completed trials

6 Sponsors

6 Countries

Phase III

Phase II

Phase IV

Phase I (Other)

Phase III: 2 Phase II: 1 Phase IV: 2 Phase I (Other): 1

Indications tested

6 total

RATE: Reduced anticoagulation targets in extracorporeal life support Pending

2023-509675-16-01 Phase III 1 country Universitair Medisch Centrum Groningen
The Intensive Care Platform Trial (INCEPT) Recruiting

2024-516208-41-00 Phase IV 5 countries Rigshospitalet
DISTINCT: inDividual, targeted thrombosIS prophylaxis versus the standard ‘one size fits all’ approach in patients undergoing Total hIp or t… Recruiting

2023-510186-98-00 Phase IV 1 country Academisch Ziekenhuis Leiden
ISCHEMIA Recruiting

2024-511679-14-00 Phase II 1 country Amsterdam UMC Stichting
RIVACAST - RIVAroxaban versus low-molecular weight heparin in patients with lower limb trauma requiring brace or CASTing Recruiting

2023-509905-62-00 Phase III 1 country Centre Hospitalier Universitaire D'Angers
Effects of NT-0796 in Healthy Volunteers and Patients with Parkinson’s Disease Ended

2023-503203-29-00 Phase I (Other) 1 country Nodthera Limited

Showing 1–6 of 6 trials